DE69733142D1 - Substituierte benzocycloheptapyridine derivate verwendbar als farnesyl-protein transferase inhibitoren - Google Patents

Substituierte benzocycloheptapyridine derivate verwendbar als farnesyl-protein transferase inhibitoren

Info

Publication number
DE69733142D1
DE69733142D1 DE69733142T DE69733142T DE69733142D1 DE 69733142 D1 DE69733142 D1 DE 69733142D1 DE 69733142 T DE69733142 T DE 69733142T DE 69733142 T DE69733142 T DE 69733142T DE 69733142 D1 DE69733142 D1 DE 69733142D1
Authority
DE
Germany
Prior art keywords
protein transferase
farnesyl protein
derivatives useful
transferase inhibitors
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69733142T
Other languages
English (en)
Other versions
DE69733142T2 (de
Inventor
F Rane
B Cooper
K Mallams
J Doll
George Njoroge
G Taveras
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DE69733142D1 publication Critical patent/DE69733142D1/de
Publication of DE69733142T2 publication Critical patent/DE69733142T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DE69733142T 1996-09-13 1997-09-11 Substituierte benzocycloheptapyridine derivate verwendbar als farnesyl-protein transferase inhibitoren Expired - Fee Related DE69733142T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71370596A 1996-09-13 1996-09-13
US713705 1996-09-13
PCT/US1997/015902 WO1998011097A1 (en) 1996-09-13 1997-09-11 Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase

Publications (2)

Publication Number Publication Date
DE69733142D1 true DE69733142D1 (de) 2005-06-02
DE69733142T2 DE69733142T2 (de) 2006-03-16

Family

ID=24867191

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69733142T Expired - Fee Related DE69733142T2 (de) 1996-09-13 1997-09-11 Substituierte benzocycloheptapyridine derivate verwendbar als farnesyl-protein transferase inhibitoren

Country Status (13)

Country Link
EP (1) EP0931077B1 (de)
JP (1) JP2001500506A (de)
KR (1) KR20000036102A (de)
CN (1) CN1104428C (de)
AT (1) ATE294172T1 (de)
AU (1) AU4337597A (de)
CA (1) CA2264666A1 (de)
DE (1) DE69733142T2 (de)
ES (1) ES2242232T3 (de)
HU (1) HUP0000073A3 (de)
IL (1) IL128926A0 (de)
NZ (1) NZ334341A (de)
WO (1) WO1998011097A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613905B1 (en) 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
EP1047675A1 (de) 1998-01-21 2000-11-02 Millennium Pharmaceuticals, Inc. Chemokinrezeptor-antagonisten und verfahren zur verwendund
US6329385B1 (en) 1998-01-21 2001-12-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6509346B2 (en) 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7271176B2 (en) 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7541365B2 (en) 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
EP1656156A2 (de) 2003-08-13 2006-05-17 Children's Hospital Medical Center Mobilisierung pluripotenter hämapoietischer stammzellen
CA2611530C (en) 2005-06-23 2012-11-20 Merck & Co., Inc. Tyrosine kinase inhibitors
TW200813021A (en) 2006-07-10 2008-03-16 Merck & Co Inc Tyrosine kinase inhibitors
CA2657247A1 (en) 2006-07-28 2008-01-31 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
US8546563B2 (en) 2007-11-07 2013-10-01 Boehringer Ingelheim International Gmbh Compounds which modulate the CB2 receptor
JP5749162B2 (ja) 2008-07-10 2015-07-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Cb2受容体を調節するスルホン化合物
AU2009296838A1 (en) 2008-09-25 2010-04-01 Boehringer Ingelheim International Gmbh Sulfonyl compounds which selectively modulate the CB2 receptor
EP2398771B1 (de) 2009-02-18 2015-07-29 Boehringer Ingelheim International GmbH Den cb2-rezeptor modulierende heterocyclische verbindungen
US8299103B2 (en) 2009-06-15 2012-10-30 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the CB2 receptor
EP2443107B1 (de) * 2009-06-16 2018-08-08 Boehringer Ingelheim International GmbH Azetidin 2 -carboxamidderivate als cb2-rezeptormodulatoren
JP2013505295A (ja) 2009-09-22 2013-02-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Cb2受容体を選択的に調節する化合物
JP2013517271A (ja) 2010-01-15 2013-05-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Cb2受容体を調節する化合物
US8329735B2 (en) 2010-03-05 2012-12-11 Boehringer Ingelheim International Gmbh Tetrazole compounds which selectively modulate the CB2 receptor
WO2012012307A1 (en) 2010-07-22 2012-01-26 Boehringer Ingelheim International Gmbh Sulfonyl compounds which modulate the cb2 rece
EP2803668A1 (de) 2013-05-17 2014-11-19 Boehringer Ingelheim International Gmbh Neuartige (Cyano-dimethyl-methyl)-isoxazole und -[1,3,4]-thiadiazole

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593417A (en) * 1976-12-22 1981-07-15 Squibb & Sons Inc Carbocyclic-fused pyrazolopyridine derivatives
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
IE68935B1 (en) * 1990-06-22 1996-07-24 Schering Corp Bis-benzo or benzopyrido cyclohepta piperidene piperidylidene and piperazine compounds compositions and methods of use
TW308594B (de) * 1993-10-15 1997-06-21 Schering Corp
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them

Also Published As

Publication number Publication date
EP0931077B1 (de) 2005-04-27
EP0931077A1 (de) 1999-07-28
ES2242232T3 (es) 2005-11-01
NZ334341A (en) 2001-01-26
IL128926A0 (en) 2000-02-17
JP2001500506A (ja) 2001-01-16
CA2264666A1 (en) 1998-03-19
KR20000036102A (ko) 2000-06-26
DE69733142T2 (de) 2006-03-16
CN1104428C (zh) 2003-04-02
AU4337597A (en) 1998-04-02
HUP0000073A3 (en) 2002-02-28
ATE294172T1 (de) 2005-05-15
HUP0000073A2 (hu) 2001-10-28
CN1236365A (zh) 1999-11-24
WO1998011097A1 (en) 1998-03-19

Similar Documents

Publication Publication Date Title
DE69733142D1 (de) Substituierte benzocycloheptapyridine derivate verwendbar als farnesyl-protein transferase inhibitoren
ATE345338T1 (de) Tricyclische piperdinyl derivate verwendbar als farnesyl-protein transferase inhibitoren
ATE242231T1 (de) Carbonyl-piperaznyl und piperidinyl derivate zur hemmung farnesyl protein transferase
ATE259365T1 (de) Chinolinderivate verwendbar zur hemmung der farnesyl-protein transferase
DE69332860D1 (de) Bicyklische fibrinogen antagoniste
MY117290A (en) Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation
ES2120728T3 (es) Inhibidores de la agregacion de plaquetas.
ATE356816T1 (de) Trizyklische keto amid derivative als farnesyl protein transferase inhibitoren
CA2293358A1 (en) Tricyclic sulfonamide inhibitors of farnesyl-protein transferase
ATE237611T1 (de) Cyclische harnstoff- und lactamderivate von benzo(5,6)cycloheptapyridinen zur verwendung als farnesyl-protein-transferase-hemmer
ATE299140T1 (de) Farnesyl-protein transferase inhibitoren
EA200001248A1 (ru) Новые линейные и циклические производные мочевины, способ их получения и их содержащие фармацевтические композиции
EA200101170A1 (ru) Галоидпроизводные 9-деоксо-9а-аза-9а-гомоэритромицина а
ES2192671T3 (es) Compuestos triciclicos que tienen actividad como inhibidores de ras-fpt.
ATE218137T1 (de) Benzo(5,6)cyclohepta(1,2-b)pyridin derivate als farnesyl protein transferase inhibitoren
US5712261A (en) Method for preventing or treating hypertriglyceridemia
NO982363L (no) Fosfonsyrederivater med metallopeptidasehemmende aktivitet
DE69722002D1 (de) Tricyclische n-cyanoimine als inhibitoren der farnesyl-protein transferase
DE69817826D1 (de) Benzo[5,6]cyclohepta[1,2b]pyridine derivate anwendbar als farnesyl protein transferase inhibitoren
ATE236149T1 (de) Tricyclische aminooxyamide derivate als farnesyl protein transferase inhibitoren
NO991232D0 (no) Substituerte benzosykloheptapyridinderivater anvendelige for inhibering av farnesylproteintransferase

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee